Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study-Reference-Cited by-同舟云学术

Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study

Published:2016-06 Issue:6 Volume:16 Page:661-673
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Carmeli Yehuda,Armstrong Jon,Laud Peter J,Newell Paul,Stone Greg,Wardman Angela,Gasink Leanne B

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference16 articles.

1. Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action;Carlet;Antimicrob Resist Infect Control,2012

2. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control;Tangden;J Intern Med,2015

3. Pseudomonas aeruginosa: resistance to the max;Poole;Front Microbiol,2011

4. Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration;Lerner;Clin Microbiol Infect,2015

5. Multidrug-resistant Gram-negative bacteria: a product of globalization;Hawkey;J Hosp Infect,2015

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlled trials;Journal of Infection and Chemotherapy;2024-11

2. A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria;International Journal of Antimicrobial Agents;2024-09

3. Ceftazidime-avibactam versus other antimicrobial agents for treatment of Multidrug-resistant Pseudomonas aeruginosa: a systematic review and meta-analysis;Infection;2024-08-24

4. Combining deep learning and droplet microfluidics for rapid and label-free antimicrobial susceptibility testing of colistin;Biosensors and Bioelectronics;2024-08

5. Effectiveness of novel β-lactams for Pseudomonas aeruginosa infection: A systematic review and meta-analysis;American Journal of Infection Control;2024-07